QHSLab nine-month revenue $1.99M; retires convertible notes, eliminates dilution overhang

QHSLab, Inc.

Nine-month 2025 revenue $1.99M, up 32% YoY from $1.51M; gross profit $1.32M.
Unaudited October revenue ~$285k, implying annualized run rate over $3.4M.
Retired two overdue convertible notes (18% interest, $0.20 conversion) removing over $1.4M in liabilities.
DTC float only 2,429,525 shares; structural dilution risk eliminated.
Company expects strong momentum into 2026, focusing on scaling digital-health revenues.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.